SCHEMBL14047402

SCHEMBL14047402

CC1N=C(n2cnn(Cc3ccc(F)cc3)c2=O)SC1C(=O)NCc1cccnc1

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 17/20 0.62
▸ GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13393741 0.91 SCD (0.49) SCD
SCHEMBL14047580 0.78 SCD (0.50) SCD
SCHEMBL13393740 0.77 CACNA1G (0.43) SCD
SCHEMBL245328 0.77 SCD (1.00) SCD
SCHEMBL14162281 0.77 SCD (0.45) SCDGAA
SCHEMBL14047577 0.75 KMT2A (0.43) SCDGAA
SCHEMBL245376 0.75 SCD (0.77) SCD
SCHEMBL14480159 0.73 SCD (0.62) SCDGAA
SCHEMBL12717805 0.73 SCD (0.62) SCDGAA
SCHEMBL14047544 0.72 SCD (0.59) SCDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008127349-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL NOVARTIS AG (CH) 2008-10-23 — — WO disclosed
Send feedback